Sight Sciences
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2011-01-01
- Employees
- 214
- Market Cap
- -
- Website
- http://www.sightsciences.com
- Introduction
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Clinical Trials
16
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
OMNI 3.0 Surgical System in Subjects With Primary Open-Angle Glaucoma
- Conditions
- Primary Open Angle Glaucoma
- First Posted Date
- 2025-05-27
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT06991270
- Locations
- 🇵🇦
Panama Eye Center, Panama City, Panama
A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)
- Conditions
- Primary Open Angle GlaucomaCataract
- First Posted Date
- 2025-04-29
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT06948773
- Locations
- 🇵🇦
Panama Eye Center, Panama City, Panama
A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma
- Conditions
- Primary Open Angle Glaucoma
- Interventions
- Device: OMNI Surgical System
- First Posted Date
- 2024-05-09
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT06407973
- Locations
- 🇺🇸
North Bay Eye Associates, Petaluma, California, United States
🇺🇸University Eye Specialists, Maryville, Tennessee, United States
A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System
- Conditions
- Glaucoma, Open-Angle
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT05044793
- Locations
- 🇺🇸
Grene Vision Group, Wichita, Kansas, United States
🇺🇸Oklahoma Eye Surgeons, Oklahoma City, Oklahoma, United States
🇺🇸Northern Ophthalmics, Jenkintown, Pennsylvania, United States
An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseudophakic Eyes With Primary Open Angle Glaucoma (ORION 2.0)
- Conditions
- Glaucoma, Open-Angle
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Sight Sciences, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT04872348
- Locations
- 🇺🇸
Eye Specialists of Georgia, Atlanta, Georgia, United States
🇺🇸Grene Vision Group, Wichita, Kansas, United States
🇺🇸Minnesota Eye Consultants, Bloomington, Minnesota, United States
- Prev
- 1
- 2
- 3
- 4
- Next
News
OMNI® Surgical System Shows Long-Term Efficacy in Comprehensive 22-Study Meta-Analysis for Glaucoma Treatment
Meta-analysis of 22 studies demonstrates significant long-term intraocular pressure reduction and decreased medication dependence using the OMNI® Surgical System for glaucoma treatment.